Your browser doesn't support javascript.
loading
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.
Kasenda, B; Ihorst, G; Schroers, R; Korfel, A; Schmidt-Wolf, I; Egerer, G; von Baumgarten, L; Röth, A; Bloehdorn, J; Möhle, R; Binder, M; Keller, U; Lamprecht, M; Pfreundschuh, M; Valk, E; Fricker, H; Schorb, E; Fritsch, K; Finke, J; Illerhaus, G.
Afiliação
  • Kasenda B; Department of Haematology/Oncology, Klinikum Stuttgart, Stuttgart, Germany.
  • Ihorst G; Department of Medical Oncology & Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
  • Schroers R; Clinical Trials Unit, Medical Centre - University of Freiburg, Freiburg, Germany.
  • Korfel A; Department of Medicine, Hematology and Oncology, Ruhr-University of Bochum, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany.
  • Schmidt-Wolf I; Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine, Berlin, Germany.
  • Egerer G; Department of Internal Medicine III, Center for Integrated Oncology (CIO), University Hospital Bonn, Bonn, Germany.
  • von Baumgarten L; Department of Haematology and Oncology, Heidelberg University, Heidelberg, Germany.
  • Röth A; Department of Neurology, University Hospital Munich LMU, Munich, Germany.
  • Bloehdorn J; Medical Faculty, Department of Haematology, University of Duisburg-Essen, Essen, Germany.
  • Möhle R; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Binder M; Department of Haematology and Oncology, University Tübingen, Tübingen, Germany.
  • Keller U; Department of Oncology and Hematology, University of Hamburg, Hamburg, Germany.
  • Lamprecht M; III Medical Department, Technische Universität München, Munich, Germany.
  • Pfreundschuh M; Department of Internal Medicine II, University Hospital of Schleswig-Holstein, Campus Kiel, Germany.
  • Valk E; Klinik für Innere Medizin I, Universität des Saarlandes, Homburg, Germany.
  • Fricker H; Department of Haematology/Oncology, Klinikum Stuttgart, Stuttgart, Germany.
  • Schorb E; Department of Haematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany.
  • Fritsch K; Department of Haematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany.
  • Finke J; Department of Haematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany.
  • Illerhaus G; Department of Haematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany.
Leukemia ; 31(12): 2623-2629, 2017 12.
Article em En | MEDLINE | ID: mdl-28559537

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Sistema Nervoso Central / Transplante de Células-Tronco Hematopoéticas / Linfoma Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Sistema Nervoso Central / Transplante de Células-Tronco Hematopoéticas / Linfoma Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha